InProBioTech.com
Title
InPro Biotechnology
Description
Under the direction and leadership of Nobel laureate Dr. Stanley B. Prusiner, InPro Biotechnology, Inc. brings 30 years of prion research to the global campaign against diseases caused by mis-folded proteins known as prions. InPro was founded in 2000 to optimize and commercialize prion diagnostic and disinfectant products, developed in Dr. Prusiner’s laboratory at the University of California San Francisco, in order to make these advanced technologies widely available to the global campaign to combat prion diseases.
Stanley B. Prusiner, M.D. is Founder and Chairman of the Board of InPro Biotechnology. Dr. Prusiner is Director of the Institute for Neurodegenerative Diseases and Professor of Neurology and Biochemistry at the University of California, San Francisco. From 1969 to 1972, he served in the US Public Health Service at the National Institutes of Health. Editor of eight books and author of over 250 research articles, Prusiner's contributions to scientific research have been internationally recognized. He is a member of the National Academy of Sciences, the Institute of Medicine, the American Academy of Arts and Sciences, the American Philosophical Society, and he is a foreign member of the Royal Society, London. He is the recipient of numerous prizes, including the Potamkin Prize for Alzheimer's Disease Research from the American Academy of Neurology (1991), the Richard Lounsbery Award for Extraordinary Scientific Research in Biology and Medicine from the National Academy of Sciences (1993), the Gairdner Foundation International Award (1993), the Albert Lasker Award for Basic Medical Research (1994), the Paul Ehrlich Prize from the Federal Republic of Germany (1995), the Wolf Prize in Medicine from the State of Israel (1996), the Keio International Award for Medical Science (1996), the Louisa Gross Horwitz Prize from Columbia University (1997), and the Nobel Prize in Physiology or Medicine (1997). Dr. Prusiner is recognized as the world's leading expert on prions, their conformation and the pathology of prion related diseases.
